Archives
All entries, chronologically...

In one of the first studies of its kind, UCLA researchers used a unique brain scan to assess the levels of amyloid plaques and neurofibrillary tangles — the hallmarks of Alzheimer’s disease — in adults with Down syndrome. Published in the June edition of the Archives of Neurology, the finding may offer an additional clinical tool to help diagnose dementia in adults with Down syndrome, which is a genetic disorder caused by the presence of a complete or partial extra copy of chromosome 21.

The healthy brain has balance of excitatory and inhibitory signals that stimulate activity but also keep it under control. Some brain diseases, like autism and Down’s syndrome, have too much inhibition, which impairs cognitive functions. Reducing inhibition appears to improve cognition, and it can restore juvenile plasticity in the adult brain, making it more adaptable. Scientists want to recapture this plasticity to enhance recovery from stroke or brain injury and to treat people suffering from developmental or degenerative brain disorders. Now, a new MIT study using a common antidepressant that coincidentally reduces neural inhibition shows how this “disinhibition” works in ways that might be used therapeutically.